FIND DOCTORS
-
Name: Ren, Yu-lan
Department: Department of Gynecologic Oncology
Title: M.D., Ph.D., Associated ProfessorEducation & Professional Experience Jan 2015 ~ till now the associated professor, Department of Gynecology Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China
Feb, 2014 ~ May 2014 visiting scholar, Department of Gynecologic Oncology, M.D.Anderson Cancer Center, U.S.A.
May, 2014 ~ Oct 2014 visiting scholar, Department of Obstetrics and Gynecology, Stanford University, U.S.A.
July, 2009 ~ Dec 2014 the attending surgeon, Department of Gynecology Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China
July, 2008 ~ July, 2009 resident, Department of Gynecology Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China
Sep, 2003~July, 2008 Shanghai Cancer Center, Fudan University; M.D., Ph.D. Degree
Sep, 2002~June, 2003 Intern, The Sheng-Li hospital of Shandong Medical University. Jinan, Shandong Provinec, China
Sep, 1997-July, 2003 Shandong Medical University; Medical Bachelor’s DegreeSpecialty Specialized in the surgery and treatment of gynecologic malignancies, including uterine tumor, cervical cancer, and ovarian, as well as the minimally invasive surgery, such as laparoscopic surgery. Research Focused on the study of uterine cancer and ovarian cancer.
Research Projects:
1.“The research on CpG hypermethylation of microRNAs in molecular pathogenesis of endometrial cancer and its target genes”, doctoral Foundation of Ministry of Education of China, Jan, 2012~Dec, 2014, as the director of project.
2.“The research on tumor suppressor gene hypermethylation to predict lymph node metastases in endometrial cancer”, funded by Fudan University, Jan, 2010~Dec, 2011, as the director of project.
3.“The research on WIF-1 and CDH1 gene hypermethylation in type I and type II endometrial cancer”, funded by Shanghai Cancer Center, Jan, 2009~Dec, 2010, as the director of project.Publication 1.Yulan Ren, Boer Shan, Daren Shi, Huaying Wang*. Salvage Cytoreductive Surgery for Patients with Recurrent Endometrial Cancer: a Retrospective Study. BMC Cancer, 2014;14:135.
2.Yulan Ren，Huaying Wang，Boer Shan, Bo Ping, Daren Shi. Clinical implications of positive peritoneal cytology in endometrial cancer. Zhong Hua Fu Chan Ke Za Zhi, 2011,46 (8)：595-599.
3.Yulan Ren，Huaying Wang，Xiaoyan Zhou, Boer Shan, Wentao Yang, Lei Shen, Daren Shi. Clinical significance of Her-2/neu status in patients with uterine papillary serous carcinoma. Zhong Hua Fu Chan Ke Za Zhi, 2010,45 (5): 367-371.
4.Yulan Ren，Huaying Wang. Advancement of target therapy in endometrial cancer, China Oncology, 2010,20 (5):397-400.
5.Yulan Ren，Huaying Wang，Shi Daren, Wentao Yang, et al. Combined treatment and prognostic factors for stage Ⅲand Ⅳ endometrial carcinoma. Zhong Hua Fu Chan Ke Za Zhi, 2008, 43(7):523-527.
6.Yulan Ren，Huaying Wang，Lei Shen，Wentao Yang. Clinical and pathologic analysis of 33 cases of uterine papillary serous carcinoma. Zhong Hua Fu Chan Ke Za Zhi, 2006,12, 817-821.
7.Yulan Ren，Huaying Wang. The Relationship between Menopausal State and Prognosis of Endometrial Cancer. The Practicla Journal of Cancer, 2006, 21(1): 59-62.
8.Huaying Wang, Jianmin Sun, Hongfen Lu, Daren Shi, Yulan Ren, Siqing Fu. Micrometastases Detected by Molecular Techniques for Cytokeratin 19 in Sentinel Lymph Nodes of Patients with Cervical Cancer. Int J Gynecol Cancer,2006, 16, 643-648.
9.Yulan Ren，Huaying Wang，Lei Shen. Research advances in uterine papillary serous carcinoma. China Oncology, 2004, 14, (4): 383-386.Awards 1.2006 Excellent Doctor of Fudan University Cancer Hospital
2.2006 the first grade of Scholarship of Fudan University
3.2005 The Research of “Clinical study and basic research on patients with invasive cervical cancer by multidisciplinary therapy ”gained the third prize of Shanghai Science and Technology Advances.
4.2005 The Research of “Micrometastases Detected by Molecular Techniques for Cytokeratin 19 in Sentinel Lymph Nodes of Patients with Cervical Cancer” gained the third prize in Clinical Researcho of Fudan University Cancer Hospital.Out-patient Schedule Every Monday afternoon (1:30 PM~4:30 PM)
